TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.

Edward Chesney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.